N.B. not covering RSV vaccine for seniors
Arexvy was approved by Health Canada in Aug. for people aged 60 and older and costs an estimated $270 per dose in N.B. The Coalition for Seniors and Nursing Home Residents' Rights calls the decision to not publicly fund the RSV vaccine unacceptable